Infused Total Nucleated Cell Dose is a Better Predictor of Transplant Outcomes Than CD34+ Cell Dose for Peripheral Blood Allogeneic Hematopoietic Cell Transplantation in Children

被引:0
|
作者
Wells, Joseph Russell [1 ]
Sunkara, Anusha [2 ]
Kang, Guolian [2 ]
Hale, Jennifer [1 ]
Hughes, Carlton [1 ]
Alloush, Lina [1 ]
Madden, Renee [1 ]
Qudeimat, Amr [1 ]
Mamcarz, Ewelina [1 ]
Leung, Wing H. [1 ]
Janssen, William [1 ]
Triplett, Brandon M. [1 ]
Srinivasan, Ashok [1 ]
机构
[1] St Jude Childrens Res Hosp, Bone Marrow Transplantat & Cellular Therapy, 332 N Lauderdale St, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
582
引用
收藏
页码:S396 / S397
页数:2
相关论文
共 50 条
  • [1] Infused total nucleated cell dose is a better predictor of transplant outcomes than CD34+ cell number in reduced-intensity mobilized peripheral blood allogeneic hematopoietic cell transplantation
    Martin, Paul S.
    Li, Shuli
    Nikiforow, Sarah
    Alyea, Edwin P., III
    Antin, Joseph H.
    Armand, Philippe
    Cutler, Corey S.
    Ho, Vincent T.
    Kekre, Natasha
    Koreth, John
    Luckey, John
    Ritz, Jerome
    Soiffer, Robert J.
    HAEMATOLOGICA, 2016, 101 (04) : 499 - 505
  • [2] Effect of Total Nucleated and CD34+ Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation
    Remberger, Mats
    Torlen, Johan
    Ringden, E.
    Engstrom, Mats
    Watz, Emma
    Uhlin, Michael
    Mattsson, Jonas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (05) : 889 - 893
  • [3] Impact of a Low CD34+ Cell Dose on Allogeneic Peripheral Blood Stem Cell Transplantation
    Yamamoto, Chihiro
    Ogawa, Hiroyasu
    Fukuda, Takahiro
    Igarashi, Aiko
    Okumura, Hirokazu
    Uchida, Naoyuki
    Hidaka, Michihiro
    Nakamae, Hirohisa
    Matsuoka, Ken-Ichi
    Eto, Tetsuya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kanda, Yoshinobu
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (04) : 708 - 716
  • [4] The impact of the CD34+ cell dose on engraftment in allogeneic peripheral blood stem cell transplantation
    Ilhan, O
    Arslan, Ö
    Arat, M
    Beksaç, M
    Akan, H
    Özcan, M
    Gürman, G
    Konuk, N
    Uysal, A
    Koç, H
    TRANSFUSION SCIENCE, 1999, 20 (01): : 69 - 71
  • [5] Impact of transplanted CD34+ cell dose in allogeneic unmanipulated peripheral blood stem cell transplantation
    S K Sohn
    J G Kim
    D H Kim
    N Y Lee
    J S Suh
    K B Lee
    Bone Marrow Transplantation, 2003, 31 : 967 - 972
  • [6] Impact Of Total Nucleated Cell and CD34+Cell Dose On Transplant Related Outcomes In Reduced Intensity Conditioning Allogeneic Hematopoietic Cell Transplants
    Martin, Paul
    Li, Shuli
    Alyea, Edwin P.
    Ho, Vincent T.
    Cutler, Corey S.
    Armand, Philippe
    Koreth, John
    Luckey, Chance J.
    Kao, Grace
    Ritz, Jerome
    Antin, Joseph H.
    Soiffer, Robert J.
    BLOOD, 2013, 122 (21)
  • [7] CD34+ CELL DOSE OF MARROW GRAFT PREDICTS OUTCOMES IN PEDIATRIC RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
    Suliman, Ali Y.
    Wells, Joseph R.
    Sunkara, Anusha
    Kang, Guolian
    Hughes, Carlton
    Alloush, Lina
    Hale, Jennifer
    Qudeimat, Amr
    Akel, Salem
    Triplett, Brandon
    Srinivasan, Ashok
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [8] Transplant CD34+ cell dose affects outcomes following allogeneic peripheral blood stem cell transplantation from a matched unrelated donor.
    Nakamura, R
    Palmer, J
    Rodriguez, R
    Parker, P
    Senitzer, D
    Stein, A
    Rosenthal, J
    Wang, S
    Schriber, J
    Forman, SJ
    Nademanee, A
    BLOOD, 2005, 106 (11) : 581A - 582A
  • [10] Controlling T cell dose in CD34+ allogeneic transplant
    Loudovaris, M
    Unverzagt, K
    Yacob, D
    Jaramillo, J
    Bender, J
    Deans, R
    BONE MARROW TRANSPLANTATION, 1998, 21 : S100 - S100